Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Mar 19 2026
Oct 11 2025
Dec 24 2025
Sep 9 2025
Jan 10 2026